Lotrel - 54868-5783-0 - (amlodipine besylate and benazepril hydrochloride)

Alphabetical Index


Drug Information of Lotrel

Product NDC: 54868-5783
Proprietary Name: Lotrel
Non Proprietary Name: amlodipine besylate and benazepril hydrochloride
Active Ingredient(s): 5; 40    mg/1; mg/1 & nbsp;   amlodipine besylate and benazepril hydrochloride
Administration Route(s): ORAL
Dosage Form(s): CAPSULE
Coding System: National Drug Codes(NDC)

Labeler Information of Lotrel

Product NDC: 54868-5783
Labeler Name: Physicians Total Care, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020364
Marketing Category: NDA
Start Marketing Date: 20070620

Package Information of Lotrel

Package NDC: 54868-5783-0
Package Description: 10 CAPSULE in 1 BOTTLE, PLASTIC (54868-5783-0)

NDC Information of Lotrel

NDC Code 54868-5783-0
Proprietary Name Lotrel
Package Description 10 CAPSULE in 1 BOTTLE, PLASTIC (54868-5783-0)
Product NDC 54868-5783
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name amlodipine besylate and benazepril hydrochloride
Dosage Form Name CAPSULE
Route Name ORAL
Start Marketing Date 20070620
Marketing Category Name NDA
Labeler Name Physicians Total Care, Inc.
Substance Name AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
Strength Number 5; 40
Strength Unit mg/1; mg/1
Pharmaceutical Classes Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient],Angiontensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE]

Complete Information of Lotrel


General Information